High Growth Tech Stocks in Asia Featuring Three Prominent Companies

Simply Wall St

Tue, January 13, 2026 at 5:36 PM EST 4 min read

As global markets experience a rally, with small-cap stocks leading the charge, Asian tech companies are capturing investor interest amid optimism in the domestic tech sector and strong market turnover. In this environment, identifying high-growth tech stocks involves looking for companies that demonstrate resilience and adaptability in response to evolving economic conditions and policy changes.

Click here to see the full list of 181 stocks from our Asian High Growth Tech and AI Stocks screener.

Below we spotlight a couple of our favorites from our exclusive screener.

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Medy-Tox Inc. is a biopharmaceutical company based in South Korea with a market capitalization of ₩832.54 billion.

Operations: Medy-Tox Inc. generates revenue primarily from its biotechnology segment, amounting to approximately ₩241.80 billion. The company’s operations focus on the development and commercialization of biopharmaceutical products in South Korea.

Medy-Tox has demonstrated remarkable financial agility, with earnings surging by 103.6% over the past year, significantly outpacing the Biotech industry’s growth of 44.3%. This performance is underpinned by a robust annual earnings forecast of 49.9%, eclipsing the broader Korean market’s expectation of 33.5%. Additionally, recent strategic moves to stabilize its stock price through a share repurchase program reflect a proactive approach to enhancing shareholder value; from late November to early December 2025 alone, Medy-Tox repurchased nearly 24,000 shares for KRW 2.999 billion. This blend of aggressive financial growth and strategic market maneuvers positions Medy-Tox as a dynamic player in Asia’s high-growth tech landscape.

• Click to explore a detailed breakdown of our findings in Medy-Tox’s health report.

• Gain insights into Medy-Tox’s historical performance by reviewing our past performance report.

Simply Wall St Growth Rating: ★★★★★★

Overview: Asia Vital Components Co., Ltd., along with its subsidiaries, specializes in providing thermal solutions globally and has a market capitalization of NT$522.10 billion.